Recent VIR Stock Price | VIR Stock Predictions | |
$9.18 | +221.35% |
$29.50 |
Recent VIR Analyst Ratings Breakdown, Making VIR Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 5 | 5 | 5 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.78 | 1.78 | 1.78 | 1.78 |
For the VIR stock predictions from the analysts covering Vir Biotechnology Inc, we have collected all of the individual VIR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering VIR (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since VIR stock predictions may vary widely, another useful metric to consider is the median VIR stock prediction, which represents the price at which half of the analysts
made VIR stock predictions that were higher and half made VIR stock predictions that were lower. This makes for a different take on the VIR stock predictions out there, as compared to average or mean.
And that median across all the individual VIR stock predictions was: $17.5 as of 2024-05-03.
The very highest of the VIR stock predictions for one year price target was $110.0, while the very lowest of the VIR stock predictions in the analyst group was
$10.0 (with a standard deviation of $33.2). Get the latest Zacks research report on VIR — FREE
Find out: VIR next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CLSK Stock Predictions
PE Stock Predictions
LSTR Stock Predictions
JRVR Stock Predictions
ITRI Stock Predictions
SGC Stock Predictions
BEP Stock Predictions
PRAH Stock Predictions
SSP Stock Predictions
|
|
Buy (3.22 out of 4) 45th percentile
(ranked lower than approx. 55% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |